Screening for Chlamydia trachomatis infection is indicated for women under 30 using emergency contraception
- PMID: 12413621
- DOI: 10.1016/s0010-7824(02)00387-6
Screening for Chlamydia trachomatis infection is indicated for women under 30 using emergency contraception
Abstract
A total of 838 women attending a large family planning clinic in Scotland for emergency contraception were offered screening for Chlamydia trachomatis infection. 569 were screened using ligase chain reaction test in first void urine at the time of presenting for emergency contraception and were retested 1 or 2 weeks later. Women aged under 20 and over 30 years were significantly more likely to decline to be tested than women aged 20 to 30. The prevalence of chlamydia was 7.6% in woman aged 24 or less, 5.3% in women aged 25 to 29, and 1.2% in women aged 30 or more. Only two women (< 1%) who tested negative at the time of using EC were positive 1 or 2 weeks later. Women under age 30 who use EC should be offered screening for chlamydia infection and testing at the time they attend for EC is adequate to detect the great majority of infected women.
Comment in
-
Screening for Chlamydia trachomatis in the pharmacy?Contraception. 2003 Jun;67(6):491; author reply 492. doi: 10.1016/s0010-7824(03)00072-6. Contraception. 2003. PMID: 12814820 No abstract available.
Similar articles
-
Provision of Chlamydia trachomatis screening in family planning clinics and emergency contraception in genitourinary medicine clinics: a collaborative cross-speciality survey.J Fam Plann Reprod Health Care. 2002 Oct;28(4):185-8. doi: 10.1783/147118902101196810. J Fam Plann Reprod Health Care. 2002. PMID: 12419057
-
Screening for asymptomatic urogenital Chlamydia trachomatis infection at a large Dublin maternity hospital: results of a pilot study.Ir J Med Sci. 2017 May;186(2):393-397. doi: 10.1007/s11845-016-1429-3. Epub 2016 Mar 11. Ir J Med Sci. 2017. PMID: 26969456
-
Risk factors for Chlamydia trachomatis infection in 6810 young women attending family planning clinics.Int J STD AIDS. 1992 Mar-Apr;3(2):117-22. doi: 10.1177/095646249200300208. Int J STD AIDS. 1992. PMID: 1571382
-
Screening for Chlamydia trachomatis infection in women and aspects of the laboratory diagnostics.Acta Obstet Gynecol Scand. 1991;70(7-8):587-90. doi: 10.3109/00016349109007921. Acta Obstet Gynecol Scand. 1991. PMID: 1785275
-
Chlamydia trachomatis infection in a gynaecology clinic population: identification of high-risk groups and the value of contact tracing.Eur J Obstet Gynecol Reprod Biol. 1989 Apr;31(1):67-74. doi: 10.1016/0028-2243(89)90027-0. Eur J Obstet Gynecol Reprod Biol. 1989. PMID: 2653896 Review.
Cited by
-
STI testing in emergency contraceptive consultations.Br J Gen Pract. 2015 Feb;65(631):63. doi: 10.3399/bjgp15X683449. Br J Gen Pract. 2015. PMID: 25624285 Free PMC article. No abstract available.
-
Who Is Best to Test? A Systematic Review of Chlamydia Infections in Switzerland.Int J Environ Res Public Health. 2020 Dec 15;17(24):9389. doi: 10.3390/ijerph17249389. Int J Environ Res Public Health. 2020. PMID: 33333868 Free PMC article.
-
Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London.Qual Saf Health Care. 2007 Aug;16(4):303-7. doi: 10.1136/qshc.2006.020883. Qual Saf Health Care. 2007. PMID: 17693680 Free PMC article.
-
Exploring pharmacy and home-based sexually transmissible infection testing.Sex Health. 2015 Nov;12(6):472-9. doi: 10.1071/SH15031. Sex Health. 2015. PMID: 26409484 Free PMC article.
-
Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study.BMC Womens Health. 2009 Mar 26;9:7. doi: 10.1186/1472-6874-9-7. BMC Womens Health. 2009. PMID: 19323804 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical